Effect of meal replacement on metabolic risk factors in overweight and obese subjects
- PMID: 18319587
- DOI: 10.1159/000119416
Effect of meal replacement on metabolic risk factors in overweight and obese subjects
Abstract
Aim: Our objective was to assess alterations in metabolic risk factors, body weight, fat mass and hormonal parameters following 6 weeks of lifestyle intervention with increased physical activity and either a meal-replacement regimen or a low calorie diet.
Research methods and procedures: 90 overweight or obese subjects (age 47 +/- 7.5 years, weight 90.6 +/- 11.3 kg, BMI 31.5 +/- 2.3) were included in this randomized controlled clinical trial. Subjects in the fat-restricted low-calorie-diet group (LCD-G; n = 30) received 2 dietary counseling sessions and instructions on how to increase physical activity. Subjects in the meal-replacement-diet group (MRD-G; n = 60) received the same lifestyle education and were instructed to replace 2 daily meals by a low-calorie high soy-protein drink.
Results: Subjects in the MRD-G lost significantly more weight (6.4 vs. 3.1 kg, p < 0.01) and fat mass (5.1 vs. 2.8 kg, p < 0.01) than the LCD-G. Most metabolic risk parameters were reduced in both the MRD-G and the LCD-G; however, subjects in the MRD-G showed a higher reduction in waist circumference (6.1 vs. 1.8 cm, p < 0.01) and a larger decrease in triglycerides (-19.6 vs. +12.5 mg/dl, p < 0.01). The prevalence of the metabolic syndrome was reduced in subjects in the MRD-G only (-12%, p < 0.05) compared to an unchanged risk score in the LCD-G. The reductions in leptin (18.2 vs. 6.97 ng/ml) and insulin (4.92 vs. 0.58 microU/ml) were only significant in the MRD-G (p < 0.01).
Discussion: Our data suggest that even over a short period of time, a meal-replacement diet is more effective in reducing metabolic risk factors, insulin, and leptin, and in improving anthropometric measures than a fat-restricted low-calorie diet.
(c) 2008 S. Karger AG, Basel.
Similar articles
-
Short-term low calorie diet intervention reduces serum advanced glycation end products in healthy overweight or obese adults.Ann Nutr Metab. 2009;54(3):197-201. doi: 10.1159/000217817. Epub 2009 May 6. Ann Nutr Metab. 2009. PMID: 19420913
-
High protein diets decrease total and abdominal fat and improve CVD risk profile in overweight and obese men and women with elevated triacylglycerol.Nutr Metab Cardiovasc Dis. 2009 Oct;19(8):548-54. doi: 10.1016/j.numecd.2008.10.006. Epub 2009 Jan 29. Nutr Metab Cardiovasc Dis. 2009. PMID: 19179060
-
The effect of a low-fat, high-protein or high-carbohydrate ad libitum diet on weight loss maintenance and metabolic risk factors.Int J Obes (Lond). 2009 Mar;33(3):296-304. doi: 10.1038/ijo.2008.278. Epub 2009 Jan 20. Int J Obes (Lond). 2009. PMID: 19153580 Clinical Trial.
-
[Obesity and cardiovascular diseases-theoretical background and therapeutic consequences].Z Kardiol. 2004 Jul;93(7):503-13. doi: 10.1007/s00392-004-0082-4. Z Kardiol. 2004. PMID: 15243761 Review. German.
-
Adiposopathy: how do diet, exercise and weight loss drug therapies improve metabolic disease in overweight patients?Expert Rev Cardiovasc Ther. 2006 Nov;4(6):871-95. doi: 10.1586/14779072.4.6.871. Expert Rev Cardiovasc Ther. 2006. PMID: 17173503 Review.
Cited by
-
Exercise and Weight Management: The Role of Leptin-A Systematic Review and Update of Clinical Data from 2000-2022.J Clin Med. 2023 Jul 5;12(13):4490. doi: 10.3390/jcm12134490. J Clin Med. 2023. PMID: 37445524 Free PMC article. Review.
-
A soy-yoghurt-honey product as a therapeutic functional food: mode of action and narrative review.Heliyon. 2022 Oct 10;8(11):e11011. doi: 10.1016/j.heliyon.2022.e11011. eCollection 2022 Nov. Heliyon. 2022. PMID: 36353168 Free PMC article. Review.
-
Effect of Two Meal Replacement strategies on Cardiovascular Risk Parameters in Advanced Age Patients with Obesity and Osteoarthritis.Nutrients. 2020 Apr 1;12(4):976. doi: 10.3390/nu12040976. Nutrients. 2020. PMID: 32244696 Free PMC article. Clinical Trial.
-
Clinical and metabolic response to soy administration in older women with metabolic syndrome: a randomized controlled trial.Diabetol Metab Syndr. 2019 Jun 20;11:47. doi: 10.1186/s13098-019-0441-y. eCollection 2019. Diabetol Metab Syndr. 2019. PMID: 31249633 Free PMC article.
-
Is Chickpea a Potential Substitute for Soybean? Phenolic Bioactives and Potential Health Benefits.Int J Mol Sci. 2019 May 29;20(11):2644. doi: 10.3390/ijms20112644. Int J Mol Sci. 2019. PMID: 31146372 Free PMC article. Review.
